Retrospective Evaluation of Bone Turnover Markers in Serum for the Prediction of Metastases Development in Breast Cancer Patients: A Cohort Study.
Mariz KasohaSebastian FindekleeMeletios P NigdelisGilda SchmidtErich-Franz SolomayerBashar Haj HamoudPublished in: Biomedicines (2024)
Serum bone turnover markers (e.g., ICTP) were able to predict the development of osseous metastases but were not associated with oncologic outcomes. Further investigation and validation are required for the use of such markers in clinical practice.